Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 500 entries
View as:

Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)

Phase: N/A Priority: Normal
NCT ID: NCT00794846 Org: User:
Start: 12/31/02 End: 05/31/03 Due: 05/31/04

Sitosterolemia Extension Study (0653-004)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00092820 Org: User:
Start: 02/12/01 End: 11/30/04 Due: 11/30/05

Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)

Phase: N/A Priority: Normal
NCT ID: NCT01144416 Org: User:
Start: 06/30/10 End: 04/30/12 Due: 04/30/13

FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

Phase: N/A Priority: Normal
NCT ID: NCT00398931 Org: User:
Start: 02/28/98 End: 10/31/03 Due: 10/31/04

A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)

Phase: N/A Priority: Normal
NCT ID: NCT03882905 Org: User:
Start: 01/31/01 End: 07/27/01 Due: 07/27/02

Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)

Phase: N/A Priority: Normal
NCT ID: NCT00817076 Org: User:
Start: 03/31/03 End: 07/31/03 Due: 07/31/04

Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)

Phase: N/A Priority: Normal
NCT ID: NCT01685424 Org: User:
Start: 06/30/06 End: 03/01/15 Due: 03/01/16

Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)

Phase: N/A Priority: Normal
NCT ID: NCT00671528 Org: User:
Start: 07/31/09 End: 05/31/10 Due: 05/31/11

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

Phase: N/A Priority: Normal
NCT ID: NCT00535405 Org: User:
Start: 11/30/07 End: 03/31/09 Due: 03/31/10

A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)

Phase: N/A Priority: Normal
NCT ID: NCT01277211 Org: User:
Start: 09/19/11 End: 09/18/13 Due: 09/18/14

Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00733005 Org: User:
Start: 07/31/08 End: 10/31/08 Due: 10/31/09

A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00308347 Org: User:
Start: 05/31/96 End: 04/30/01 Due: 04/30/02

Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

Phase: N/A Priority: Normal
NCT ID: NCT01277822 Org: User:
Start: 05/30/11 End: 04/22/13 Due: 04/22/14

Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)

Phase: N/A Priority: Normal
NCT ID: NCT01566149 Org: User:
Start: 03/31/12 End: 09/30/12 Due: 09/30/13

Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)

Phase: N/A Priority: Normal
NCT ID: NCT01437111 Org: User:
Start: 10/26/11 End: 12/05/12 Due: 12/05/13

A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)

Phase: N/A Priority: Normal
NCT ID: NCT00092651 Org: User:
Start: 09/30/02 End: 06/30/03 Due: 06/30/04

MK0462 in Treatment of Migraine With Recurrence (MK0462-022)

Phase: N/A Priority: Normal
NCT ID: NCT00897949 Org: User:
Start: 03/31/95 End: 07/31/96 Due: 07/31/97

Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00782184 Org: User:
Start: 11/30/08 End: 09/30/10 Due: 09/30/11

A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

Phase: N/A Priority: Normal
NCT ID: NCT00704444 Org: User:
Start: 06/30/07 End: 09/30/09 Due: 09/30/10

Analgesic Treatment Mediated by Arcoxia (0663-093)

Phase: N/A Priority: Normal
NCT ID: NCT00380523 Org: User:
Start: 04/30/05 End: 05/31/05 Due: 05/31/06

Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)

Phase: N/A Priority: Normal
NCT ID: NCT00424008 Org: User:
Start: 04/30/07 End: 11/30/08 Due: 11/30/09

Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00920361 Org: User:
Start: 11/30/05 End: 03/31/09 Due: 03/31/10

Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)

Phase: N/A Priority: Normal
NCT ID: NCT00400218 Org: User:
Start: 09/01/05 End: 07/19/06 Due: 07/19/07

Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00156104 Org: User:
Start: 07/01/05 End: 09/16/06 Due: 09/16/07

Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)

Phase: N/A Priority: Normal
NCT ID: NCT01190267 Org: User:
Start: 09/28/10 End: 10/07/13 Due: 10/07/14